camostat has been researched along with calcimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CH; Chang, TM; Chey, WY; Leiter, A; Sun, Q | 1 |
Fujii, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 1 |
2 other study(ies) available for camostat and calcimycin
Article | Year |
---|---|
Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1.
Topics: Animals; Bombesin; Bucladesine; Calcimycin; Cholecystokinin; Colforsin; Cyclic AMP; Diterpenes; Dose-Response Relationship, Drug; Esters; Fatty Alcohols; Gabexate; Gene Expression; Guanidines; Mice; Tumor Cells, Cultured | 1994 |
Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Administration, Oral; Amylases; Animals; Calcimycin; Carbachol; Cholecystokinin; Esters; Gabexate; Guanidines; In Vitro Techniques; Male; Pancreas; Rats; Rats, Wistar; Secretin; Sincalide; Tetradecanoylphorbol Acetate; Trypsin Inhibitors | 1995 |